Trademark: 79298748
Word
BYVASDA
Status Date
Tuesday, August 17, 2021
Registration Number
6451033
Registration Date
Tuesday, August 17, 2021
Filing Date
Wednesday, September 23, 2020
Published for Opposition
Tuesday, June 1, 2021
5 Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for medical purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable pharmaceuticals for treatment of anaphylactic reactions
The mark consists of stylized letters "BYVASDA" and a dandelion on its left side.
Feb 14, 2022
Final Decision Transaction Processed By Ib
Jan 25, 2022
Final Disposition Notice Sent To Ib
Jan 25, 2022
Final Disposition Processed
Nov 17, 2021
Final Disposition Notice Created, To Be Sent To Ib
Aug 17, 2021
Registered-Principal Register
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 23, 2021
Approved For Pub - Principal Register
Apr 2, 2021
Teas/Email Correspondence Entered
Apr 1, 2021
Correspondence Received In Law Office
Apr 1, 2021
Teas Response To Office Action Received
Feb 21, 2021
Refusal Processed By Ib
Feb 3, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Feb 3, 2021
Refusal Processed By Mpu
Jan 16, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jan 15, 2021
Non-Final Action Written
Jan 12, 2021
Assigned To Examiner
Dec 4, 2020
Application Filing Receipt Mailed
Nov 30, 2020
New Application Office Supplied Data Entered In Tram
Nov 26, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
